Neuroscience News

A new analysis of a vaccination program in Wales by a Knight Initiative–supported team found that the shingles vaccine appeared to lower new dementia diagnos

Knight Initiative–supported research by Pascal Geldsetzer and colleagues adds to evidence that preventing the viral infection can help stave off cognitive de

New Alzheimer's biomarkers focus on whether Alzheimer's has actually begun to affect a person's thinking and memory, rather than just amyloid levels.

Psychiatrist Anna Lembke shares what scientists have discovered so far about the potential for GLP-1s in addiction treatment.

Young adults crave closeness, says Stanford psychologist Jamil Zaki, but often misjudge how much their peers want that, too.

In a recent study of a technique to help kids with ADHD strengthen their working memory, about half of participants showed improvements in their symptoms.

This week on the podcast, Stanford radiology faculty Kim Butts Pauly and Raag Airan help us dive deep into the brain with focused ultrasound

Neurotech trainee Favour Nerrise is among 10 grad students who will have three minutes to engage the audience—and a panel of judges—with their research proje

By studying never-before-seen details of brain connectivity in human infants, researchers at the Wu Tsai Neurosciences Institute have identified how a balance of innate structure and flexible learning produces our remarkably organized visual brains.

In the lab of Lauren O’Connell, associate professor of biology, researchers look to amphibian species to learn how animals evolve in response to changing env

Three teams developing promising neurotechnologies with the potential for tremendous impact on human well-being have been named recipients of the 2025 Neuroscience:Translate awards from the Wu Tsai Neurosciences Institute at Stanford.

Our brains and digestive tracts are in constant communication.

This week on the podcast, Stanford psychiatry professor Erin Gibson joins us again to share the latest findings on sleep, myelin, and neurodegenerative disease.

Stanford researchers have created a compound that relieves multiple types of pain in mice without building tolerance or causing psychoactive side effects.

Gordon Wang, director of the Neuroscience Microscopy Service Community Lab at Wu Tsai Neuro, and his team are studying integrated stress response inhibitor (ISRIB) as a potential treatment for Fragile X syndrome, aiming to restore brain function and improve social behavior.

New findings about the sugary armor on the brain’s frontline cells could shed light on cognitive decline and diseases like Alzheimer’s—and open new avenues f